(Q57214985)

English

Challenges in translating preclinical studies to effective drug therapies in idiopathic pulmonary fibrosis

article published in 2010

In more languages

edit

Statements

0 references

0 references

Challenges in translating preclinical studies to effective drug therapies in idiopathic pulmonary fibrosis (English)

0 references

1 reference

idiopathic pulmonary fibrosis

1 reference

Victor J Thannickal

1

0 references

Jesse Roman

series ordinal

2

0 references

language of work or name

English

0 references

publication date

15 March 2010

0 references

published in

American Journal of Respiratory and Critical Care Medicine

0 references

volume

181

0 references

issue

6

0 references

page(s)

532-3

0 references

cites work

Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200911-1740ED

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1740ED

retrieved

21 January 2018

Innovative approaches to the therapy of fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200911-1740ED

retrieved

21 January 2018

Improving the standard of care for patients with idiopathic pulmonary fibrosis requires participation in clinical trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200911-1740ED

retrieved

21 January 2018

Intracellular tyrosine kinases as novel targets for anti-fibrotic therapy in systemic sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200911-1740ED

retrieved

21 January 2018

Protein kinase inhibitors in the treatment of pulmonary fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200911-1740ED

retrieved

21 January 2018

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200911-1740ED

retrieved

21 January 2018

Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200911-1740ED

retrieved

21 January 2018

Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200911-1740ED

retrieved

21 January 2018

Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200911-1740ED

retrieved

21 January 2018

Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200911-1740ED

retrieved

21 January 2018

Imatinib mesylate inhibits fibrogenesis in asbestos-induced interstitial pneumonia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200911-1740ED

retrieved

21 January 2018

The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200911-1740ED

retrieved

21 January 2018

Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200911-1740ED

retrieved

21 January 2018

Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200911-1740ED

retrieved

21 January 2018

Identifiers

DOI

10.1164/RCCM.200911-1740ED

0 references

PubMed publication ID

20208038

0 references

(Q57214985)

Challenges in translating preclinical studies to effective drug therapies in idiopathic pulmonary fibrosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)